Proper Extent of Maze Intercaval Lesion
| Status: | Withdrawn |
|---|---|
| Conditions: | Atrial Fibrillation |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 6/1/2018 |
| Start Date: | April 15, 2018 |
| End Date: | April 15, 2019 |
It's hypothesized that a mean and range distance from the cavo-atrial junction to the area
where there is complete loss of conductive tissue can be measured to better inform surgeons
performing the Cox-Maze procedure. A patient scheduled for any cardiac surgery where
visualization and mapping of cavo-atrial junction is possible could be entered into the study
if they meet the inclusion/exclusion requirements.
where there is complete loss of conductive tissue can be measured to better inform surgeons
performing the Cox-Maze procedure. A patient scheduled for any cardiac surgery where
visualization and mapping of cavo-atrial junction is possible could be entered into the study
if they meet the inclusion/exclusion requirements.
Inclusion Criteria:
- Age ≥ 18 years male or female
- Scheduled for any cardiac surgery where visualization and mapping of cavo-atrial
junction is possible
- Subjects willing and able to provide written informed consent
Exclusion Criteria:
- Subjects receiving surgery with non-sternotomy access
- Presence of or history of transvenous pacing leads
- Subjects receiving a re-do cardiac surgery
- Subjects with a history of pericarditis
- Subjects who are in atrial fibrillation or atrial flutter and cannot be converted out
of it.
- Any medical condition or finding for which the Investigator used medical discretion to
determine the subject should be excluded
- Subject is currently participating in another clinical trial.
- Subject is unable to provide written informed consent.
We found this trial at
1
site
Plano, Texas 75093
Principal Investigator: Timothy George, M.D
Phone: 469-814-4183
Click here to add this to my saved trials
